Pfizer, through the Better Business Bureau's National Advertising Division, disputes that Novartis's Theraflu 'starts to work in the body in 5 minutes.'
Arena's recent quarter shows weight-loss drug Belviq is on the rise. It follows a DTC push and the recent addition of reps by co-marketer Eisai.
Stand Up To Cancer is kicking off a PSA that features Grammy-winner Jennifer Hudson and a Genentech scientist.
The American Academy of Pediatricians says an AstraZeneca drug for preemies should be used less often, and the drugmaker is fighting back with an ad campaign that says the new guidelines put too many at risk.
The drugmaker received a notice from the advertising watchdog over promotion of hep. B treatment Viread in a sponsored link on Google AdWords.
A US Pharma juror's—and silver Lions Health winner's—opinion on why the Americans didn't fare well in Cannes, and tips for improvement
Celebrity endorsement, co-pay cards and online edutainment are some of the ways marketers are dueling for attention in the prescription omega-3 space.
With pollen season approaching its peak, drugmakers are educating doctors on a new class of allergy tablets. It could be a while before they're made available for patients.
The AIDS Healthcare Foundation took out an ad in some WSJ editions saying the drug threatens to "break the bank."
Actress, choreographer and "So You Think You Can Dance" judge Debbie Allen has signed on to participate with the drugmaker's type 2 diabetes awareness and wellness program.
AbbVie's "Perspectives—Art, Inflammation and Me," an exhibit centered around inflammatory diseases, looks to offer patient perspective through an artistic medium.
These ads take aim at the aging male population. How well do they do at hitting their target?
Well-conceived disease awareness communications can be a powerful vehicle in establishing an urgent, emotional connection with an audience
These days, hitting the target in ads is ever more critical. These five ads are up to the challenge.
Displaying an in-your-face, post-digital sensibility, these global campaigns tell provocative stories to instigate behavioral change
The EpiPen manufacturer's latest effort: an e-book that shows children making allergy-friendly swaps at a school event.
The company is supporting its professional pitch for the acne drug with a micro-targeted marketing strategy.
Images that dramatize physical problems with an almost nightmarish spin make for compelling brand messages in six top-notch advertisements
How Shire's new campaign seeks to help diabetics start off on the right foot
The company narrowed its second quarter loss, but said its national TV campaign is driving an uptick in consumer interest.
Novo redoubled its Victoza marketing efforts after a recent setback, and that's made things tougher for GLP-1 rivals Bristol-Myers Squibb and AstraZeneca.
The drug maker's broadcast-heavy "OAB reality" campaign stresses the emotional toll on women.
23andMe aired its first TV ad Monday, in a bid to build the audience for DNA sequencing.
Print reaches readers when they are engaging with ideas. These ads show how to make that connection pay off.
Whether serious or humorous, the right "line" can stand alone, transcend the need for an accompanying visual, and become iconic in its own right.
If pharma advertising can stimulate gut instincts—with contrasts like before/after, risky/safe, with/without—it will be more effective
When a solution to a manageable condition is combined with an inspirational consumer insight, healthcare marketing can deliver a laugh along with an indelible message
Taking a look at who different pharmacies are, or maybe who they want us to think they are, today
Audrey Fleisher, VP, Group Creative Director at Digitas Health
Taking a look at some creative approaches agencies have taken to help make a product jump off the page
Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.
- Novartis psoriasis drug approval could upend market
- Sandoz gets ready to make the biosimilar case with oncologists
- Guidemark Health jumpstarts rebrand, brings on big-agency grad
- MM&M's 5 minutes with: Mark Rothera, chief commercial officer, PTC Therapeutics
- Nurse practitioner workforce has just about doubled